Dendritic cells (DCs) are potent antigen-presenting cells that constitute a major component
of the immune system's role in the recognition, elimination, and tolerance of cancer. The …

Traditionally, vaccines have helped eradication of several infectious diseases and also
saved millions of lives in the human history. Those prophylactic vaccines have acted through …

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor
vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of …

DCs1 are antigen-presenting cells that regulate several components of the immune system.
The mature or terminal stage of DC development induces specific T-cell immunity and …

Dendritic cells (DCs) are specialized antigen‐presenting cells whose immunogenicity leads
to the induction of antigen‐specific immune responses. DCs can easily be generated ex vivo …

Dendritic cells (DCs) play a crucial role in the induction of antigen-specific T-cell responses,
and therefore their use for the active immunotherapy of malignancies has been studied with …

Dendritic cells are professional antigen-presenting cells with a key role in both immunity
induction and tolerance maintenance. Dendritic cells are highly specialized in antigen …

The use of dendritic cells (DC) in cancer immunotherapy is based on their potent abilities to
present antigens, so they can act as 'natural adjuvants' to enhance immunogenicity of tumor …

For many cancers the use of conventional chemotherapy has been maximized, and further
intensification of chemotherapy generally results in excess toxicity with little long-term …

Dendritic cells (DC) are the most efficient antigen presenting cells in various in vitro systems
and DC are now introduced to early clinical use. Tumor antigen loaded DC might potentially …